PF-Atlas › Исследования › Switzerland Pharma
Исследования: Switzerland Pharma (13)
13 публикаций в теме «Switzerland Pharma», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Pharmacological Evaluation of Novel Pyrimido-Diazepine Derivatives As Pulmonary Anti-Fibrotic Drugs On Animal Fibrosis Model in rats · Journal of Veterinary Medical Research · 2025
- The novel AT2 receptor ligand, β-Pro7 Ang III, induces equivalent anti-fibrotic effects to Compound 21 but broader anti-fibrotic effects than pirfenidone in mice with bleomycin-induced pulmonary fibrosis · Clinical Science · 2025
- Survival Analysis of Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis and Emphysema Patients Treated With Anti-fibrotic Agents: A Multi-centre Cohort Study · American Journal of Respiratory and Critical Care Medicine · 2025
- Review for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2023
- Review for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2023
- Review for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2023
- Decision letter for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2023
- Decision letter for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2023
- Review for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2022
- Review for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2022
- Decision letter for "Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis" · CrossRef · 2022
- Anti-Fibrotic Agents Could Be the Game Changer for Post‑COVID Pulmonary Fibrosis Treatment – A Mini Review · CrossRef · 2021
- GED-0507 as a Novel Potential Anti-Fibrotic Treatment Option for Pulmonary Fibrosis · A62. LUNG FIBROSIS: INSIGHTS FROM THE BENCH · 2020
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.